Cardiac tumorgenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction
Abstract
Aim: Genetic reprogramming of somatic cells with stemness genes to restore their pluripotent status is being studied extensively to generate pluripotent stem cells as an alternative to embryonic stem cells. This study was designed to examine the effectiveness of skeletal myoblast-derived induced pluripotent stem cells (SkiPS) from young male Oct4/GFP transgenic mice for regeneration of the infarcted heart. Methods & results: A mouse model of permanent coronary artery ligation was developed in young female immunocompetent C57BL/6J or C57BL/6x129S4 SV/jae Oct4/GFP mice. SkiPS labeled with Q-dots (3 × 105 in 10 µl basal Dulbecco’s modified Eagle’s medium) were transplanted in and around the area of infarct immediately after coronary artery ligation (n = 16) under direct vision. Control mice (n = 12) were injected with the same number of skeletal myoblasts. Histological studies documented successful engraftment of SkiPS in all the surviving animals 4 weeks later. However, six of the 16 SkiPS-transplanted (37.5%) animal hearts showed intramural teratomas, whereas no tumor growth was observed in the control mice. Q-dot-labeled donor cells were also observed at the site of tumors. Histological studies revealed that teratomas were composed of cells from all of the three embryonic germ layers. Ultra-structure studies confirmed the histological findings and showed regions with well-organized myofibrillar structures in the tumors. Conclusion: Undifferentiated induced pluripotent stem cells should not be recommended for cardiac transplantation unless screened for specific teratogenic precursors or predifferentiated into cardiac lineage prior to transplantation.
Bibliography
- 1 Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126,663–676 (2006).
- 2 Lowry WE, Plath K: The many ways to make an iPS cell. Nat. Biotechnol.26,1246–1248 (2008).
- 3 Kuzmenkin A, Liang H, Xu G et al.: Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. FASEB J.23,4168–4180 (2009).
- 4 Nelson TJ, Martinez-Fernandez A, Yamada S et al.: Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation120,408–416 (2009).
- 5 Niagara MI, Haider H, Jiang S et al.: Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ. Res.100,545–555 (2007).
- 6 Lu G, Haider HK, Jiang S et al.: Sca1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexion-43. Circulation119,2587–2596 (2009).
- 7 Dai Y, Ashraf M, Zuo S et al.: Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repair. J. Mol. Cell Cardiol.44,607–617 (2008).
- 8 Nelson TJ, Ge ZD, Van Orman J et al.: Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells. Anat. Rec. A Discov. Mol. Cell Evol. Biol.288,1216–1224 (2006).
- 9 Caspi O, Huber I, Kehat I et al.: Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol.50,1884–1893 (2007).
- 10 Kehat I, Gepstein L: Electrophysiological coupling of transplanted cardiomyocytes. Circ. Res.101,433–435 (2007).
- 11 Nussbaum J, Minami E, Laflamme MA et al.: Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J.21,1345–1357 (2007).
- 12 Nakagawa M, Koyanagi M, Tanabe K et al.: Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol.26,101–106 (2008).
- 13 Stadtfeld M, Nagaya M, Utikal J et al.: Induced pluripotent stem cells generated without viral integration. Science322,945–949 (2008).
- 14 Martinez-Fernandez A, Nelson TJ,Ikeda Y et al.: c-MYC independentnuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells. J. Cardiovasc. Transl. Res.3,13–23(2010).
- 15 Blum B, Bar-Nur O, Golan-Lev T et al.: The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat. Biotechnol.27,281–287 (2009).
- 16 Yoon YS, Park JS, Tkebuchava T et al.: Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation109,3154–3157 (2004).
- 17 Behfar A, Perez-Terzic C, Faustino RSet al.: Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J. Exp. Med.204,405–420 (2007).
